Tricuspid repair with the Cardioband valve reconstruction system resulted in a significant and sustained decrease in tricuspid regurgitation (TR), with all 37 patients improving by at least one grade at 1 year in the ongoing U.S. Cardioband TR early feasibility study (EFS).